Omnicell Profit Margin 2010-2023 | OMCL

Current and historical gross margin, operating margin and net profit margin for Omnicell (OMCL) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Omnicell net profit margin as of December 31, 2023 is -1.78%.
Omnicell Annual Profit Margins
Omnicell Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.206B $1.147B
Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $38.875B 21.62
Inspire Medical Systems (INSP) United States $7.378B 0.00
10x Genomics (TXG) United States $3.475B 0.00
IRhythm Technologies (IRTC) United States $3.470B 0.00
Axonics (AXNX) United States $3.427B 0.00
Enovis (ENOV) United States $3.084B 23.43
Azenta (AZTA) United States $2.854B 232.59
Olink Holding AB (publ) (OLK) Sweden $2.772B 0.00
Hims & Hers Health (HIMS) United States $2.659B 0.00
Privia Health (PRVA) United States $2.118B 93.95
Schrodinger (SDGR) United States $1.811B 0.00
Phreesia (PHR) United States $1.306B 0.00
Definitive Healthcare (DH) United States $0.847B 0.00
Standard BioTools (LAB) United States $0.757B 0.00
Fulgent Genetics (FLGT) United States $0.601B 0.00
Talkspace (TALK) United States $0.497B 0.00
Health Catalyst (HCAT) United States $0.329B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.316B 0.00
Clover Health Investments (CLOV) United States $0.308B 0.00
Pulmonx (LUNG) United States $0.286B 0.00
Butterfly Network (BFLY) United States $0.171B 0.00
P3 Health Partners (PIII) United States $0.158B 0.00
Augmedix (AUGX) United States $0.155B 0.00
American Well (AMWL) United States $0.149B 0.00
MSP Recovery (LIFW) United States $0.131B 0.00
TruBridge (TBRG) United States $0.122B 5.19
Outset Medical (OM) United States $0.112B 0.00
111 (YI) China $0.081B 0.00
SHL Telemedicine (SHLT) Israel $0.076B 0.00
Future Health ESG (FHLT) United States $0.076B 0.00
HeartBeam (BEAT) United States $0.057B 0.00
Zepp Health (ZEPP) China $0.051B 0.00
EUDA Health Holdings (EUDA) Singapore $0.042B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.033B 0.00
Movano (MOVE) United States $0.026B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Cue Health (HLTH) United States $0.023B 0.00
Streamline Health Solutions (STRM) United States $0.021B 0.00
ETAO (ETAO) United States $0.019B 0.00
CareCloud (CCLD) United States $0.019B 0.00
Strata Skin Sciences (SSKN) United States $0.018B 0.00
Akili (AKLI) United States $0.017B 0.00
Centogene (CNTG) Germany $0.013B 0.00
Biotricity (BTCY) United States $0.012B 0.00
Transgenomic (PRPO) United States $0.010B 0.00
Syra Health (SYRA) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.007B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00